Housemark for pharmaceutical preparations, namely, pharmaceutical preparations for assessment, treatment, and prophylaxis of osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, neurological disease, cognitive impairment, and mitochondrial health; pharmaceutical preparations for assessment, treatment, and prophylaxis for the health problems arising from the decline in organ systems, the immune system, and neurologic and cardiac function, respiratory tract infe...